Triple therapy in type 2 diabetes: Systematic review of the available evidence;Triple terapia en diabetes tipo 2: revisión sistemática de la evidencia disponible

Avances en Diabetologia

Volumn 26, Issue 4, 2010, Pages 276-280

  Ortega Millan C ^a   Fornos Perez J A ^b   Garcia Mayor R V ^c   Menendez Torre E ^d  

^a Medicina de Familia   (Spain)

^b Grupo Berbés de Investigación y Docencia   (Spain)

^c HOSPITAL XERAL CÍES   (Spain)

^d Servicio de Endocrinología y Nutrición Hospital Universitario Central de Astuiras   (Spain)

Author keywords

combination therapy; triple therapy; type 2 diabetes

Indexed keywords

INSULIN;

DISEASE ASSOCIATION; FOLLOW UP; GLYCEMIC CONTROL; HUMAN; INSULIN RESISTANCE; LONG TERM CARE; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW;

EID: 84866672482     PISSN: 11343230     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1134-3230(10)64016-1     Document Type: Article

References (36)

1. Committee C.D.A.-C.P.G.E. Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada Can J Diabetes. 3 2008 1 201
2. National Collaborating Centre for Chronic Conditions Type 2 diabetes: national clinical guideline for management in primary and secondary care (update) 2008 Royal College of Physicians London
3. D. Nathan, J. Buse, M. Davidson, E. Ferrannini, R. Holman, and R. Sherwin Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy Diabetologia. 52 2009 17 30
4. Work Group of Institute for Clinical Systems Improvement (ICSI). Diagnosis and management of type 2 diabetes mellitus in adults Thirteenth Edition/May 2009 Minnesota
5. H.W. Rodbard, P.S. Jellinger, J.A. Davidson, D. Einhorn, A.J. Garber, and G. Grunberger Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control Endocr Pract. 15 2009 540 559
6. Grupo de Trabajo de la Guía de Práctica Clínica sobre Diabetes tipo 2. Guía de práctica clínica sobre diabetes tipo 2. Madrid: Plan Nacional para el SNS del MSC. Agencia de Evaluación de Tecnologías Sanitarias del País Vasco, Guías de Práctica Clínica en el SNS: OSTEBA n.° 2006/08. 2008.
7. G.E. Dailey, M.A. Noor, J.S. Park, S. Bruce, and F.T. Fiedorek Glycemic control with glyburide/metformin tablets in combination with rosiglitazone in patients with type 2 diabetes: a randomized, double-blind trial Am J Med. 116 2004 223 229
8. G. Charpentier, and S. Halimi Earlier triple therapy with pioglitazone in patients with type 2 diabetes Diabetes Obes Metab. 11 2009 844 854
9. M. Dorkhan, M. Magnusson, A. Frid, A. Grubb, L. Groop, and S. Jovinge Glycaemic and nonglycaemic effects of pioglitazone in triple oral therapy of patients with type 2 diabetes J Intern Med. 260 2006 125 133
10. J.F. Yale, T.R. Valiquett, M.N. Ghazzi, J.K. Owens-Grillo, R.W. Whitcomb, and H.L. Foyt The effect of a thiazolidinedione drug, troglitazone, on glycemia in patients with type 2 diabetes mellitus poorly controlled with sulfonylurea and metformin: a multicenter randomized, double-blind, placebo-controlled trial for the Troglitazone Triple-Therapy Study Group. Ann Intern Med. 134 9 Pt 1 2001 737 745
11. F. Ovalle, and D.S. Bell Triple oral antidiabetic therapy in type 2 diabetes mellitus Endocr Pract. 4 1998 146 147
12. D.S. Bell, and F. Ovalle Long-term efficacy of triple oral therapy for type 2 diabetes mellitus Endocr Pract. 8 2002 271 275
13. J.A. Kiayias, E.D. Vlachou, E. Theodosopoulou, and E. Lakka-Papadodima Rosiglitazone in combination with glimepiride plus metformin in type 2 diabetic patients Diabetes Care. 25 2002 1251 1252
14. J. Byrne, S. Garg, A. Vaidya, S.M. Rajbhandari, and S.C. Wallis Efficacy of triple combination oral hypoglycaemic therapy using rosiglitazone, metformin and sulphonylurea in lowering HbA1c Practical Diabetes International. 20 2003 58 60
15. R. Roy, M. Navar, G. Palomeno, and M.B. Davidson Real world effectiveness of rosiglitazone added to maximal (tolerated) doses of metformin and a sulfonylurea agent Diabetes Care. 27 2004 1741 1742
16. V.L. Roberts, J. Stewart, M. Issa, B. Lake, and R. Melis Triple therapy with glimepiride in patients with type 2 diabetes mellitus inadequately controlled by metformin and a thiazolidinedione: results of a 30-week, randomized, double-blind, placebo-controlled, parallel-group study Clin Ther. 27 2005 1535 1547
17. S.M. Strowig, M.L. Avilés-Santa, and P. Raskin Improved glycemic control without weight gain using triple therapy in type 2 diabetes Diabetes Care. 27 2004 1577 1583
18. J. Rosenstock, D. Sugimoto, P. Strange, J.A. Stewart, E. Soltes-Rak, and G. Dailey Triple therapy in type 2 diabetes: insulin glargine or rosiglitazone added to combination therapy of sulfonylurea plus metformin in insulin-naive patients Diabetes Care. 29 2006 554 559
19. D.S. Bell Triple oral therapy for type 2 diabetes Diabetes Res Clin Pract. 78 2007 313 315
20. K.S. Lam, S.C. Tiu, M.W. Tsang, T.P. Ip, and S.C. Tam Acarbose in NIDDM patients with poor control on conventional oral agents. A 24-week placebo-controlled study Diabetes Care. 21 1998 1154 1158
21. E. Standl, G. Schernthaner, J. Rybka, M. Hanefeld, S.A. Raptis, and L. Naditch Improved glycaemic control with miglitol in inadequately-controlled type 2 diabetics Diabetes Res Clin Pract. 51 2001 205 213
22. K. Hermansen, M. Kipnes, E. Luo, D. Fanurik, H. Khatami, and P. Stein Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin. Sitagliptin Study 035 Group Diabetes Obes Metab. 9 2007 733 745
23. A. Penfornis, S. Borot, and D. Raccah Therapeutic approach of type 2 diabetes mellitus with GLP-1 based therapies Diabetes Metab. 34 Suppl 2 2008 78 90
24. S. Halimi DPP-4 inhibitors and GLP-1 analogues: for whom? Which place for incretins in the management of type 2 diabetic patients? Diabetes Metab. 34 Suppl 2 2008 91 95
25. B. Zinman, J. Gerich, J.B. Buse, A. Lewin, S. Schwartz, and P. Raskin LEAD-4 Study Investigators. Efficacy and safety of the human glucagon-like peptide-1 analog liraglutide in combination with metformin and thiazolidinedione in patients with type 2 diabetes (LEAD-4 Met+TZD) Diabetes Care. 32 2009 1224 1230
26. M.T. Tran, M.D. Navar, and M.B. Davidson Comparison of the glycemic effects of rosiglitazone and pioglitazone in triple oral therapy in type 2 diabetes Diabetes Care. 29 2006 1395 1396
27. S. Schwartz, R. Sievers, P. Strange, W.H. Lyness, and P. Hollander Insulin 70/30 mix plus metformin versus triple oral therapy in the treatment of type 2 diabetes after failure of two oral drugs: efficacy, safety, and cost analysis Diabetes Care. 26 2003 2238 2243
28. I. Lingvay, P.F. Kaloyanova, B. Adams-Huet, K. Salinas, and P. Raskin Insulin as initial therapy in type 2 diabetes: effective, safe, and well accepted J Investig Med. 55 2007 62 68
29. K. Aljabri, S.E. Kozak, and D.M. Thompson Addition of pioglitazone or bedtime insulin to maximal doses of sulfonylurea and metformin in type 2 diabetes patients with poor glucose control: a prospective, randomized trial Am J Med. 116 2004 230 235
30. R.R. Holman, K.I. Thorne, A.J. Farmer, M.J. Davies, J.F. Keenan, and S. Paul 4-T Study Group. Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes N Engl J Med. 357 2007 1716 1730
31. R.R. Holman, A.J. Farmer, M.J. Davies, J.C. Levy, J.L. Darbyshire, and J.F. Keenan Three-year efficacy of complex insulin regimens in type 2 diabetes for the 4-T Study Group N Engl J Med. 361 2009 1736 1747
32. A.I. Vinik, and Q. Zhang Adding insulin glargine versus rosiglitazone: health-related quality-of-life impact in type 2 diabetes Diabetes Care. 30 2007 795 800
33. M.K. Poulsen, J.E. Henriksen, O. Hother-Nielsen, and H. Beck-Nielsen The combined effect of triple therapy with rosiglitazone, metformin, and insulin aspart in type 2 diabetic patients Diabetes Care. 26 2003 3273 3279
34. P.D. Home, C.J. Bailey, J. Donaldson, H. Chen, and M.W. Stewart Double-blind randomized study comparing the effects of continuing or not continuing rosiglitazone + metformin therapy when starting insulin therapy in people with type 2 diabetes Diabet Med. 24 2007 618 625
35. L. Juurinen, M. Tiikkainen, J. Saltevo, K. Nikkila, H. Lanki, and E. Leppavuori Nateglinide combination therapy with basal insulin and metformin in patients with type 2 diabetes Diabet Med. 26 2009 409 415
36. A.K. Sharma, and B.P. Srinivasan Triple verses glimepiride plus metformin therapy on cardiovascular risk biomarkers and diabetic cardiomyopathy in insulin resistance type 2 diabetes mellitus rats Eur J Pharm Sci. 38 2009 433 444